SCHEMBL7030656

SCHEMBL7030656

COC(=O)[C@H](Cc1ccccc1)N(C)C

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.55
MAPT P10636 1/20 0.55
MAPK1 P28482 1/20 0.53
HTT P42858 1/20 0.53
KMT2A Q03164 3/20 0.52
MEN1 O00255 2/20 0.52
GAA P10253 2/20 0.51
ATM Q13315 1/20 0.50
CA12 O43570 1/20 0.49
CA2 P00918 1/20 0.49
CA7 P43166 1/20 0.49
CA9 Q16790 1/20 0.49
CA14 Q9ULX7 1/20 0.49
CYP2C9 P11712 2/20 0.49
CYP2C19 P33261 2/20 0.49
THRB P10828 1/20 0.49
HSD17B10 Q99714 1/20 0.49
POLB P06746 2/20 0.48
CHRM1 P11229 1/20 0.47
NPC1 O15118 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31299894 1.00 ALDH1A1 (0.55) ALDH1A1MAPTMAPK1HTTKMT2A
SCHEMBL7030654 1.00 ALDH1A1 (0.55) ALDH1A1MAPTMAPK1HTTKMT2A
SCHEMBL5151597 0.86 ATM (0.50) ALDH1A1MAPTKMT2AMEN1ATM
SCHEMBL28878522 0.86 ATM (0.50) ALDH1A1MAPTKMT2AMEN1ATM
SCHEMBL27761706 0.85 ADRA2B (0.51) ALDH1A1MAPTMAPK1HTTKMT2A
SCHEMBL17833257 0.85 ADRA2B (0.51) ALDH1A1MAPTMAPK1HTTKMT2A
SCHEMBL25657494 0.85 POLB (0.48) ALDH1A1MAPTMAPK1HTTKMT2A
SCHEMBL4157751 0.85 ATM (0.47) ALDH1A1MAPTMAPK1HTTKMT2A
SCHEMBL23072695 0.85 ESR1 (0.59) KMT2ANPC1RAB9A
SCHEMBL10369598 0.85 ALDH1A1 (0.54) ALDH1A1MAPTMAPK1HTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108250115-A The method of father's younger male cousin's amine coupling synthesizing aryl thioether 成都理工大学 2018-07-06 CN claimed
EP-0604363-B1 Stable solutions of accelerators for epoxy resins VANTICO AG (CH) 2003-02-12 EP claimed
CN-1054599-C Hydroxamic acid derivatives HOFFMANN LA ROCHE (CH) 2000-07-19 CN claimed
US-5470896-A Storage-stable solutions of accelerator systems CIBA-GEIGY CORPORATION (US) 1995-11-28 US claimed
EP-0604363-A2 Stable solutions of accelerators for epoxy resins CIBA-GEIGY AG (CH) 1994-06-29 EP claimed
CN-1082027-A Hydroxamic acid derivs HOFFMANN LA ROCHE (CH) 1994-02-16 CN claimed
US-20250129115-A1 Methods Detecting Tertiary Amines and Compositions Related Thereto UNIV EMORY (US) 2025-04-24 US disclosed
CN-113811278-B Concealment of hypomineralized lesions 墨尔本大学 2024-12-31 CN disclosed
EP-3502120-B1 PANAXDIOL-TYPE GINSENOSIDE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF UNIV ARMY MEDICAL (CN) 2022-05-25 EP disclosed
CN-105873561-B Stabilized stannous compositions 墨尔本大学 2020-02-21 CN disclosed
CN-108250115-B The method of father's younger male cousin's amine coupling synthesizing aryl thioether 成都理工大学 2019-11-08 CN disclosed
WO-2019144805-A1 SUBSTITUTED PHENYLETHYLAMINE COMPOUND AND PREPARATION METHOD AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2019-08-01 WO disclosed
CN-108569974-A Method for synthesizing m-alkyl phenylalanine methyl ester derivative through palladium and norbornene co-catalysis 江西师范大学 2018-09-25 CN disclosed
US-5470896-A Storage-stable solutions of accelerator systems CIBA-GEIGY CORPORATION (US) 1995-11-28 US disclosed
EP-0604363-A2 Stable solutions of accelerators for epoxy resins CIBA-GEIGY AG (CH) 1994-06-29 EP disclosed
CN-1082027-A Hydroxamic acid derivs HOFFMANN LA ROCHE (CH) 1994-02-16 CN disclosed
EP-0148883-B1 ALLOPURINOL PRODRUGS A/S GEA Farmaceutisk Fabrik (DK) 1990-02-14 EP disclosed
US-4694006-A Acyl- or acyloxymethyl-allopurinol prodrugs A/S GEA (DK) 1987-09-15 US disclosed
EP-0148883-A1 ALLOPURINOL PRODRUGS. GEA AS (DK) 1985-07-24 EP disclosed
WO-1985000368-A1 ALLOPURINOL PRODRUGS A/S GEA (DK) 1985-01-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250129115-A1 Methods Detecting Tertiary Amines and Compositions Related Thereto DOT1L, SETDB1, PRMT3 ALDH1A1 2419/4885MAPT 1461/4885MAPK1 3111/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.